| 5.4 -0.39 (-6.74%) | 01-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.98 | 1-year : | 8.15 |
| Resists | First : | 5.98 | Second : | 6.98 |
| Pivot price | 5.3  |
|||
| Supports | First : | 4.97 |
Second : | 4.34 |
| MAs | MA(5) : | 5.69 |
MA(20) : | 5.27 |
| MA(100) : | 4.86 |
MA(250) : | 4.08 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 71 |
D(3) : | 77.6 |
| RSI | RSI(14): 54.8 |
|||
| 52-week | High : | 6.01 | Low : | 2.34 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SRTA ] has closed below upper band by 44.3%. Bollinger Bands are 42.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 5.84 - 5.87 | 5.87 - 5.9 |
| Low: | 5.11 - 5.16 | 5.16 - 5.19 |
| Close: | 5.34 - 5.4 | 5.4 - 5.45 |
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Tue, 06 Jan 2026
Strata Critical Medical, Inc.'s (NASDAQ:SRTA) 30% Price Boost Is Out Of Tune With Revenues - simplywall.st
Wed, 31 Dec 2025
With 51% ownership of the shares, Strata Critical Medical, Inc. (NASDAQ:SRTA) is heavily dominated by institutional owners - Yahoo Finance
Fri, 12 Dec 2025
When Will Strata Critical Medical, Inc. (NASDAQ:SRTA) Breakeven? - simplywall.st
Wed, 19 Nov 2025
Strata Critical Medical: Beginning A New Journey - Seeking Alpha
Mon, 10 Nov 2025
Earnings call transcript: Strata Critical Medical’s Q3 2025 reveals revenue miss, stock rises - Investing.com
Mon, 10 Nov 2025
Strata Critical Medical Announces Third Quarter 2025 Results - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Industrials
|
|
|
Industry:
Airlines, Airports & Air Services
|
|
| Shares Out | 86 (M) |
| Shares Float | 45 (M) |
| Held by Insiders | 11.6 (%) |
| Held by Institutions | 69.4 (%) |
| Shares Short | 6,000 (K) |
| Shares Short P.Month | 4,000 (K) |
| EPS | -0.42 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.17 |
| Profit Margin | -55 % |
| Operating Margin | -42.8 % |
| Return on Assets (ttm) | -11.3 % |
| Return on Equity (ttm) | -24.5 % |
| Qtrly Rev. Growth | 208.3 % |
| Gross Profit (p.s.) | 0.15 |
| Sales Per Share | 0.77 |
| EBITDA (p.s.) | -0.36 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -22 (M) |
| Levered Free Cash Flow | -25 (M) |
| PE Ratio | -12.86 |
| PEG Ratio | 0 |
| Price to Book value | 1.29 |
| Price to Sales | 6.94 |
| Price to Cash Flow | -21.57 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|